Investing

Ocular Therapeutix : OCUL

OCUL

Stock Data

$9.43

$0.06 (0.64%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Ocular Therapeutix Inc is a pioneering biopharmaceutical firm dedicated to innovating eye care. Using its unique bioresorbable hydrogel technology, it develops treatments for various eye conditions. Its products include ReSure Sealant for cataract surgery recovery and DEXTENZA for post-surgical pain and inflammation, alongside treatments for allergic conjunctivitis. The company is also advancing research in therapies for age-related macular degeneration, glaucoma, and dry eye disease, with several products in clinical trials. Ocular Therapeutix collaborates with industry leaders like Regeneron Pharmaceuticals to enhance retinal disease treatments, marking its commitment to improving ocular health.

All Ocular Therapeutix Articles

2 Articles

Trey Thoelcke | Aug 22, 2024 at 9:15 AM EDT

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024

With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for…

Trey Thoelcke | Dec 23, 2023 at 9:03 AM EST

Buffett, Dollar Tree Purchases Highlight Pre-Christmas Insider Buying

Warren Buffett's Berkshire Hathaway has again bolstered its stake in Occidental Petroleum, and action at Dollar Tree also highlights recent…